about
Nanoengineering approaches to the design of artificial antigen-presenting cellsPD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.Uptake and transfection with polymeric nanoparticles are dependent on polymer end-group structure, but largely independent of nanoparticle physical and chemical properties.Differential polymer structure tunes mechanism of cellular uptake and transfection routes of poly(β-amino ester) polyplexes in human breast cancer cellsGold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery.Effects of base polymer hydrophobicity and end-group modification on polymeric gene deliveryGene delivery nanoparticles specific for human microvasculature and macrovasculature.Poly(β-amino ester)-nanoparticle mediated transfection of retinal pigment epithelial cells in vitro and in vivo.Non-viral gene delivery nanoparticles based on poly(β-amino esters) for treatment of glioblastoma.Small Molecule End Group of Linear Polymer Determines Cell-type Gene Delivery EfficacyPD-1/PD-L1 inhibitors.The effect and role of carbon atoms in poly(β-amino ester)s for DNA binding and gene delivery.Association of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumors.Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cellsPD-L1 Expression in Melanoma: A Quantitative Immunohistochemical Antibody Comparison.Biomimetic particles as therapeutics.Biodegradable nanoellipsoidal artificial antigen presenting cells for antigen specific T-cell activationMeasurement of PD-L1 in melanoma: a quantitative antibody comparison.Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy.Are there multiple cells of origin of Merkel cell carcinoma?Professional medical associations and the opportunity to promote breakthrough biomedical innovation.Immunoglobulin light chain repertoire in hairy cell leukemiaSomatic hypermutation and VH gene usage in hairy cell leukaemia
P50
Q27023634-80196634-6E44-40DD-91AF-B22A233E30D1Q27853379-99F3A83B-1645-4689-B249-844C7CECFAA6Q30545905-F26CA5FD-3D97-45D1-A2C6-F79918032618Q30577790-59BA8795-F825-484B-9243-1089961452A3Q33440795-078E72A1-1C9D-4568-82D4-6C25B1C4FADDQ34010079-81454C43-95C3-422C-B9B9-894E2752C406Q34150936-C4351B04-2384-4503-8182-6B60464E188DQ34281984-A7E164C8-5DED-44B8-817A-8194EF72D949Q35055311-4BCD5917-A7DE-48C0-A091-D87233379849Q35233401-7F1076DE-5C7F-4FDD-BAB4-B8BFCA1CC0C3Q35893753-524BEE8F-4785-42ED-BA47-3DC4EB04E623Q37338454-A4749E26-6965-46A6-9254-33865D5C1440Q37474092-57988F55-D2C7-4603-B4CC-58DCAABE55B0Q37515801-2082393E-5CED-46D6-8BCB-CF6A00D763A8Q38374894-E282C247-8C24-4F26-8276-60A3C4FF3BE1Q38567436-6AAE4ACF-4AC9-4BC7-B5FE-16F31FA1094EQ41495742-94BA80F1-1C69-44FD-9D2E-43A44E8C81DCQ45893698-26320D66-A909-4BFD-B549-C64BADD91BE7Q47359765-6CCA6FA0-529E-4933-BDC1-FD187CC2CFF5Q47555708-90E2DA55-30FB-4AB6-AAD8-DD1322F067AAQ49391472-40B40A65-DD01-46B4-BCDF-66AD11578AE3Q80225686-4AE3BC84-3E1C-42C8-8DDC-8F4E8D7E9C42Q83302803-9E7ACB5A-9B80-4646-AF26-020348201AA1
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Joel C Sunshine
@ast
Joel C Sunshine
@en
Joel C Sunshine
@es
Joel C Sunshine
@nl
Joel C Sunshine
@sl
type
label
Joel C Sunshine
@ast
Joel C Sunshine
@en
Joel C Sunshine
@es
Joel C Sunshine
@nl
Joel C Sunshine
@sl
prefLabel
Joel C Sunshine
@ast
Joel C Sunshine
@en
Joel C Sunshine
@es
Joel C Sunshine
@nl
Joel C Sunshine
@sl
P106
P1960
GIzdVucAAAAJ
P21
P31
P496
0000-0001-9987-6712
P569
2000-01-01T00:00:00Z